Anyone receiving retatrutide within a clinical trial should seek prompt medical advice from their trial team if they experience any of the following: Persistent or severe vomiting that prevents adequate fluid or food intake Signs of dehydration , including dizziness, reduced urination, or extreme thirst Severe or persistent abdominal pain , which may rarely indicate pancreatitis or a gallbladder problem Right upper quadrant pain, fever, or jaundice , which may suggest acute gallbladder disease (cholelithiasis or cholecystitis) a recognised risk with GLP-1-based therapies and with rapid weight loss [11] [12] Symptoms of hypoglycaemia (particularly if taking concomitant insulin or sulphonylureas), such as shakiness, sweating, or confusion Injection site reactions that are worsening, infected, or not resolving Retatrutide has not been studied in pregnancy or breastfeeding, and use during pregnancy or whilst breastfeeding is not recommended until safety data are available
Store the prepared solution at a temperature of 2-8C
Folate and Vitamin B12 supplementation, if not transfused Splenectomy Splenectomy Surgical procedure involving either partial or entire removal of the spleen
Media Contact: Mimi Carmody, [email protected] SOURCE American Diabetes Association For more information contact: Ernie Ballard, Senior Director of Communications & Marketing, [email protected], 225-263-2677
Klinic maximizes your insurance's semaglutide coverage and locates manufacturer savings and copay assistance when possible
14 days after my first dose of Moderna, my BP shot up from 130 to over 200 and heart beat 120 and difficulty breathing
